
The Pharma Letter Podcast
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
Podcasting since 2021 • 33 episodes
The Pharma Letter Podcast
Latest Episodes
Is this a revolution in Alzheimer's?
This week on The Pharma Letter Podcast, we’re joined by Howard Fillit, co-founder and chief science officer at the Alzheimer’s Drug Discovery Foundation (ADDF).As the FDA approval of anti-amyloid drugs like lecanemab and donanemab marks ...
•
Season 1
•
Episode 34
•
20:55

Why Boehringer and GSK are betting on Ochre
This week on The Pharma Letter Podcast, we’re joined by Quin Wills, co-founder and chief scientific officer of UK biotech Ochre Bio.A physician-scientist with a background in genomics and computational biology, Quin has spent much of hi...
•
Season 1
•
Episode 33
•
18:53
.png)
ICON's AI strategy: faster, smarter trials
This week on The Pharma Letter Podcast, we are joined by Tony Clarke, senior VP of IT digital operations at ICON (Nasdaq: ICLR).As a leader in digital transformation within clinical research, Tony has been at the forefront of implementin...
•
Season 1
•
Episode 32
•
15:59

How real-time data could transform clinical trials
In this week’s podcast, we welcome Iddo Peleg, CEO and co-founder of Yonalink, who provides insights into the current and future state of the clinical trial industry. As we move headlong into 2025, a year that appears set to be cha...
•
Season 1
•
Episode 31
•
15:14
.png)